The Peptide CommonsEst. May 2024
Independent. We sell nothing and are affiliated with no manufacturer or pharmacy. Every moderation action is logged in public
LC

l.cabrera

TL2 Moderator · Aarhus

Contributes reviews on supplier material. Based in Aarhus.

Joined 9 November 2024 · last posted just now

72Posts here
5Topics
0Solutions
267Likes received
176Likes given
20Badges
124Days visited
994Posts read

Most-liked posts

  • Early satiety becoming a problem rather than a benefit Started this topic · Practice › Side effects · 9 Oct 2025 · 35 likes Early satiety becoming a problem rather than a benefit — setting out what I have, and where I think it stops being reliable. A question about technique rather than…
  • Time to steady state after a dose increase Started this topic · Pharmacology › Pharmacokinetics · 1 Nov 2024 · 35 likes On the subject in the title: Time to steady state after a dose increase Working notes rather than a conclusion. A documentation question rather than an analytical one.…
  • How to ask about something you suspect is a bad idea Replied, post #87 · Start Here › How to Ask · 11 May 2026 · 32 likes Avoid "any advice?" at the end. It is so generic that people do not know which part of the post it refers to. Pick the specific part and ask that specific question…
  • Sequence verification for an obscure compound: how it is done — what changed since Replied, post #36 · Compounds › Other compounds · 23 Nov 2025 · 30 likes Naming conventions for research peptides cause confusion because suppliers do not follow a standard. The same compound gets different names from different suppliers. If…
  • Alcohol: what is documented and what is folklore Replied, post #73 · Practice › Interactions · 23 Jun 2026 · 29 likes Alcohol: no absolute contraindication but it raises gastrointestinal irritation risk and this drug class already does that. The conservative position during titration…
  • [2026 update] Composite endpoints and the component doing the work Replied, post #60 · Evidence › Trials · 7 Apr 2026 · 29 likes post #59 is right about the mechanism and I think understates the practical bit. Risk of bias: structured appraisal of internal validity. Key things to assess:…

Where this member posts

CategoryPostsShare
Practice1014%
Sourcing913%
Evidence913%
Compounds811%
Clinical68%
Access57%

Badges earned, in order

BadgeTierGranted
Basic Userbronze10 Nov 2024
Read the Guidelinesbronze15 Nov 2024
First Replybronze17 Nov 2024
Welcomebronze18 Nov 2024
First Quotebronze20 Nov 2024
Asked Wellbronze24 Nov 2024
First Topicbronze25 Nov 2024
First Linkbronze9 Dec 2024
Memberbronze30 Dec 2024
Sourcedbronze30 Dec 2024
Nice Postbronze4 Jan 2025
First Tagbronze14 Jan 2025
Nice Topicbronze4 Feb 2025
Readerbronze16 Feb 2025
Editorbronze18 Feb 2025
Good Topicsilver27 Apr 2025
Good Postsilver9 May 2025
Popular Linksilver21 Jul 2025
De-escalatorgold16 Sep 2025
Anniversarysilver9 Nov 2025